Amgen's Mixed Q2 Results Highlight Obesity Drug Potential, Analysts Focus Shifts To ...

Retrieved on: 2024-08-07 18:06:06

Tags for this article:

Click the tags to see associated articles and topics

Amgen's Mixed Q2 Results Highlight Obesity Drug Potential, Analysts Focus Shifts To .... View article details on hiswai:

Excerpt

Read Next: Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions. Market News and ...

Article found on: www.benzinga.com

View Original Article